Anebulo Pharmaceuticals I... (ANEB)
NASDAQ: ANEB
· Real-Time Price · USD
2.51
0.07 (2.87%)
At close: Aug 15, 2025, 3:59 PM
2.50
-0.40%
After-hours: Aug 15, 2025, 04:10 PM EDT
Anebulo Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Net Income | -1.68M | -2.46M | -2.2M | -1.35M | -1.65M | -2.72M | -2.48M | -2.5M | -2.8M | -3.83M | -2.61M | -2.32M | -1.88M | -1.07M | -1.55M | -29.11M | -555.83K | -328.6K | -256.38K |
Depreciation & Amortization | 245.18K | 59.7K | 59.7K | 151.23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 255.27K | 564.33K | 286.92K | 177.19 | 151.64 | 219.26 | 210.80 | 223.57 | 223.64K | 225.62 | 211.9K | 226.95K | 125.25K | 94.28K | 34.17K | 115.44K | 47.41K | 20.69K | 16.41K |
Other Working Capital | 340.1K | -408.51K | 68.41K | -711.36K | -121.41K | 899.83K | -31.4K | -540.87K | 159.44K | 919.9K | 472.30 | -201.02K | 249.64K | 230.83K | 357.55K | -763.01K | -702.69K | -24.22K | -65.42K |
Other Non-Cash Items | -426.18K | 597.39K | 59.7K | 59.7K | 145.09K | 31.84K | 179.39K | 259.92K | n/a | 153.61K | -106.28 | -70.6K | 84.92K | 545.16K | -349.6K | 26.63M | -8.07K | 4.03K | 4.03K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -164.13K | 164.13K | -939.85K | -55.17K | 652.56K | -456.8K | -577.23K | 383.79K | 991.91K | 366.01K | 96.53K | 289.97K | -220.04K | 741.32K | -734.99K | -705.14K | -106.14K | 100.98K |
Operating Cash Flow | -1.6M | -1.41M | -1.69M | -2.05M | -1.5M | -1.81M | -2.73M | -2.85M | -2.19M | -2.61M | -2.03M | -2M | -1.46M | -1.2M | -777.9K | -3.1M | -1.22M | -410.02K | -134.96K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.21M | n/a | n/a | n/a |
Other Financial Acitivies | -116.66K | 15M | n/a | n/a | n/a | -62.35K | n/a | -68.16K | n/a | -248.93K | 52.4K | n/a | n/a | n/a | n/a | 19.78M | 1.66M | n/a | n/a |
Financial Cash Flow | -116.66K | 15M | n/a | n/a | n/a | -62.35K | n/a | -68.16K | n/a | -248.93K | 6.7M | n/a | n/a | n/a | n/a | 19.78M | 1.66K | n/a | n/a |
Net Cash Flow | -1.72M | 13.59M | -1.69M | -2.05M | -1.5M | -1.88M | -2.73M | -2.92M | -2.19M | -2.86M | 4.67M | -2M | -1.46M | -1.2M | -777.9K | 16.68M | 827.08K | -410.02K | -134.96K |
Free Cash Flow | -1.6M | -1.41M | -1.69M | -2.05M | -1.5M | -1.81M | -2.73M | -2.85M | -2.19M | -2.61M | -2.03M | -2M | -1.46M | -1.2M | -777.9K | -3.1M | -1.22M | -410.02K | -134.96K |